Bone marrow NK1.1- and NK1.1+ T cells reciprocally regulate acute graft versus host disease

Journal of Experimental Medicine

Volumn 189, Issue 7, 1999, Pages 1073-1081

  Zeng, Defu ^b   Lewis, David ^b   Dejbakhsh Jones, Sussan ^b   Lan, Fengshuo ^b   García Ojeda, Marcos ^b   Sibley, Richard ^a   Strober, Samuel ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Bone marrow transplantation; Cytokines; Immune regulation; Interleukin 4; Regulatory T cells

Indexed keywords

CYTOKINE; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; FEEDBACK SYSTEM; GRAFT VERSUS HOST REACTION; IMMUNOREGULATION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT VS HOST DISEASE; H-2 ANTIGENS; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIATION CHIMERA; T-LYMPHOCYTE SUBSETS;

EID: 0033526011     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.7.1073     Document Type: Article

References (43)

1. Sullivan, K.M. 1994. Graft-versus-host disease. In Bone Marrow Transplantation. S.J. Forman, K.G. Blume, and E.D. Thomas, editors. Blackwell Scientific Publications, Boston, xxiii, 942.
2. Weisdorf, D., R. Hakke, B. Blazar, W. Miller, P. McGlave, N. Ramsay, J. Kersey, and A. Filipovich. 1991. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation. 51:1197-1203.
3. Bross, D.S., P.J. Tutschka, E.R. Farmer, W.E. Beschorner, H.G. Braine, E.D. Mellits, W.B. Bias, and G.W. Santos. 1984. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood. 63:1265-1270.
4. Ferrara, J.L., K.R. Cooke, L. Pan, and W. Krenger. 1996. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells. 14:473-489.
5. Korngold, R., and J. Sprent. 1985. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J. Immunol. 135:3004-3010.
6. Korngold, R., and J. Sprent. 1987. T cell subsets and graft-versus-host disease. Transplantation. 44:335-339.
7. Korngold, R., and J. Sprent. 1991. Graft-versus-host disease in experimental allogeneic bone marrow transplantation. Proc. Soc. Exp. Biol. Med. 197:12-18.
8. Martin, P.J., and N. Kernan. 1990. T cell depletion for GVHD prevention in humans. In Graft Versus Host Disease: Research and Clinical Management. S. Burakoff, H.J. Keeg, J. Ferrara, and K. Atkinson, editors. Marcel Dekker, Inc., New York. 371-387.
9. Burnett, A.K., I.M. Hann, A.G. Robertson, M. Alcorn, B. Gibson, I. McVicar, L. Niven, S. Mackinnon, H. Hambley, A. Morrison, et al. 1988. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation. Leukemia. 2:300-303.
10. Fauci, A.S. 1975. Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. J. Clin. Invest. 56:98-110.
11. Gale, R.P., G. Opelz, O.M. Kiuchi, and D.W. Golde. 1975. Thymus-dependent lymphocytes in human bone marrow. J. Clin. Invest. 56:1491-1498.
12. Batinic, D., M. Marusic, Z. Pavletic, V. Bogdanic, B. Uzarevic, D. Nemet, and B. Labar. 1990. Relationship between differing volumes of bone marrow aspirates and their cellular composition. Bone Marrow Transplant. 6:103-107.
13. Almaraz, R., W. Ballinger, D.H. Sachs, and S.A. Rosenberg. 1983. The effect of peripheral lymphoid cells on the incidence of lethal graft versus host disease following allogeneic mouse bone marrow transplantation. J. Surg. Res. 34:133-144.
14. Palathumpat, V., S. Dejbakhsh-Jones, B. Holm, and S. Strober. 1992. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease. J. Immunol. 149:808-817.
15. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation. 60:355-361.
16. Korngold, B., and J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148:1687-1698.
17. Vallera, D.A., C.C. Soderling, and J.H. Kersey. 1982. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants. J. Immunol. 128: 871-875.
18. + cells. J. Immunol. 145:3209-3215.
19. + T cell populations. Int. Immunol. 7:1157-1161.
20. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
21. Zeng, D., S. Dejbakhsh-Jones, and S. Strober. 1997. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood. 90: 453-463.
22. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989-2998.
23. - T-cell deficiency and IDDM in NOD/ Lt mice. Diabetes. 46:572-582.
24. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/ or IL-10. J. Exp. Med. 187:1047-1056.
25. - alpha beta bone marrow T cells with suppressor activity. J. Immunol. 148:373-380.
26. + cell lines. Cell Immunol. 129: 478-493.
27. +) T cells which promote tolerance induction and regulate autoimmunity. Immunol. Rev. 149:217-230.
28. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science. 254: 707-710.
29. Zhang, Y., K.H. Rogers, and D.B. Lewis. 1996. β2-micro-globulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 184:1507-1512.
30. Garcia-Ojeda, M.E., S. Dejbakhsh-Jones, I.L. Weissman, and S. Strober. 1998. An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J. Exp. Med. 187:1813-1823.
31. Yoshimoto, T., and W.E. Paul. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295.
32. - thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:307-310.
33. - T cells produce IL-4. J. Immunol. 149:1211-1215.
34. + lymphoid engraftment. J. Immunol. 152:1004-1013.
35. + donor T cells fail to induce experimental acute graft-versus-host disease. J. Immunol. 155:585-593.
36. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J. Immunol. 157:4811-4821.
37. Murphy, W.J., L.A. Welniak, D.D. Taub, R.H. Wiltrout, P.A. Taylor, D.A. Vallera, M. Kopf, H. Young, D.L. Longo, and B.R. Blazar. 1998. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Clin. Invest. 102:1742-1748.
38. Yang, Y.G., B.R. Dey, J.J. Sergio, D.A. Pearson, and M. Sykes. 1998. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 102:2126-2135.
39. Brok, H.P., P.J. Heidt, P.H. van der Meide, C. Zurcher, and J.M. Vossen. 1993. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151:6451-6459.
40. Sykes, M., G.L. Szot, P.L. Nguyen, and D.A. Pearson. 1995. Interleukin-12 inhibits murine graft-versus-host disease. Blood. 86:2429-2438.
41. Ellison, C.A., J.M. Fischer, K.T. HayGlass, and J.G. Gartner. 1998. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. J. Immunol. 161:631-640.
42. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
43. - T cells. J. Exp. Med. 186:109-120.